Galena Biopharma Inc (GALE):企業のM&A・提携動向(医療機器分野)

GlobalDataが出版した調査資料(GDME82624D)
◆英語タイトル:Galena Biopharma Inc (GALE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME82624D
◆発行会社(調査会社):GlobalData
◆発行日:2017年1月23日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Galena Biopharma Inc (Galena) is a biotechnology company that discovers, develops and commercializes therapies for the treatment of unmet medical needs, and advance care. Its pipeline products include NeuVax, NeuVax Present, NeuVax Hercepti, NeuVax Vadis, GALE-401 (Anagrelide CR) and GALE-301 folate binding protein for the treatment of different types of cancers such as breast cancer, gastric cancer, endometrial and ovarian cancer. The company has collaborations with National Cancer Institute, MD Anderson Cancer Center, Genentech, Kwang Dong Pharmaceutical Co. Ltd, Roche, Leica Microsystems, Teva and Dr. Reddy’s among others. Galena is headquartered in Lake Portland, Oregon, the US.

Galena Biopharma Inc (GALE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Galena Biopharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Galena Biopharma Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Galena Biopharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Galena Biopharma Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Galena Biopharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Galena Biopharma Inc, Medical Equipment, Deal Details 10
Partnerships 10
Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 10
Equity Offering 10
Galena Biopharma to Raise Funds in Public Offering of Shares 10
Galena Biopharma Raises USD12.6 Million in Private Placement of Shares and Warrants 11
Galena Biopharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares and Warrants for USD43 Million 13
Galena Biopharma Inc – Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 09, 2016: Galena Biopharma Reports Third Quarter 2016 Financial Results and Provides a Corporate Update 18
Aug 09, 2016: Galena Biopharma Reports Second Quarter 2016 Financial Results and Provides a Corporate Update 21
May 10, 2016: Galena Biopharma Reports First Quarter 2016 Financial Results and Provides a Corporate Update 24
Mar 10, 2016: Galena Biopharma Reports Fourth Quarter and Year End 2015 Financial Results and Provides a Corporate Update 27
Corporate Communications 28
Nov 03, 2016: Galena Biopharma Appoints Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer 28
Apr 26, 2016: Galena Biopharma Appoints Mary Ann Gray, Ph.D., to Its Board of Directors 29
Legal and Regulatory 31
Feb 16, 2016: Galena Biopharma Announces Proposed Settlement of Derivative Litigation 31
Other Significant Developments 32
Jan 05, 2017: Galena Biopharma to Provide Corporate and Clinical Update and 2017 Outlook During Presentation at Biotech Showcase 2017 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Galena Biopharma Inc, Medical Equipment, Key Facts, 2015 1
Galena Biopharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Galena Biopharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Galena Biopharma Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Galena Biopharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Galena Biopharma Inc, Deals By Market, 2011 to YTD 2017 8
Galena Biopharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 10
Galena Biopharma to Raise Funds in Public Offering of Shares 10
Galena Biopharma Raises USD12.6 Million in Private Placement of Shares and Warrants 11
Galena Biopharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares and Warrants for USD43 Million 13
Galena Biopharma Inc, Key Competitors 15
Galena Biopharma Inc, Key Employees 16
Galena Biopharma Inc, Subsidiaries 17

List of Figures
Galena Biopharma Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Galena Biopharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Galena Biopharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Galena Biopharma Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Galena Biopharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Galena Biopharma Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Galena Biopharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Galena Biopharma Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

★調査レポート[Galena Biopharma Inc (GALE):企業のM&A・提携動向(医療機器分野)] (コード:GDME82624D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Galena Biopharma Inc (GALE):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆